Profil
Stelios T.
Tzannis is the founder.
In 2014, he founded Mount Tam Biotechnologies, Inc. where he held the title of Head-Product Development.
Dr. Tzannis's former jobs include being the President & Chief Executive Officer at Aeonian Pharmaceuticals, Inc. from 2017 to 2019, Director-Research & Development at Nektar Therapeutics, and Principal at ALZA Corp.
Ehemalige bekannte Positionen von Stelios Tzannis
| Unternehmen | Position | Ende |
|---|---|---|
Aeonian Pharmaceuticals, Inc.
Aeonian Pharmaceuticals, Inc. BiotechnologyHealth Technology Discover, develop and commercialize innovative therapeutics for the treatment of rare and age-related diseases | Vorstandsvorsitzender | 01.06.2019 |
| ALZA CORPORATION | Corporate Officer/Principal | - |
Mount Tam Biotechnologies, Inc. /Old/
Mount Tam Biotechnologies, Inc. /Old/ BiotechnologyHealth Technology Provides medical treatment for autoimmune diseases | Gründer | - |
| NEKTAR THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Mount Tam Biotechnologies, Inc. /Old/
Mount Tam Biotechnologies, Inc. /Old/ BiotechnologyHealth Technology Provides medical treatment for autoimmune diseases | Health Technology |
Aeonian Pharmaceuticals, Inc.
Aeonian Pharmaceuticals, Inc. BiotechnologyHealth Technology Discover, develop and commercialize innovative therapeutics for the treatment of rare and age-related diseases | Health Technology |
















